Antibodies

Paper demonstrates compatibility with downstream manufacturing technologies to help accelerate CAR-T or antibody therapeutics development

New detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease

Why declining antibodies to the novel coronavirus don't spell disaster for long-lasting immunity

New COVID-SeroKlir SARS-CoV-2 IgG antibody test kit is one of first to detect both the presence and precise levels of COVID-19 neutralizing antibodies

Diagnostic test is an accurate and reliable method for determining whether individuals are protected against COVID-19

Preliminary results suggest anti-COVID-19 nanobodies may be effective at preventing and diagnosing infections

A recent study shows that, in general, the sensitivity of antibody tests was lower than the producers had stated

Heparan sulfate is increasingly recognized as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 coronavirus pandemic

Thermo Fisher and the Biopharmaceutical Analysis Training Laboratory of Northeastern University aim to deliver cutting-edge analytical solutions and training programs

The DimAb™ development platform is different from traditional hybridoma fusion technologies in that it can directly isolate IgG genes from B cells of immunized animals